# Anavex Life Sciences Corp.: Form 8-K, filed Nov 25, 2025

- Company: [Anavex Life Sciences Corp.](/companies/avxl.md) (CIK 1314052)
- Form: 8-K
- Filed: 2025-11-25
- Accepted by EDGAR: Nov 25, 2025, 07:30 ET
- Period: 2025-11-25
- Accession: 0001731122-25-001591
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1314052/000173112225001591/e7068_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1314052/000173112225001591/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1314052/000173112225001591/e7068_8k.htm

Filed Nov 25, 2025.
Source: SEC EDGAR, the filing index for accession 0001731122-25-001591. Last ingested by Listed: Nov 6, 2026, 20:17 ET. No prices; not investment advice.